Forest bathing boosts youth mental health in urban environments

Foghorn Ther­a­peu­tics said Wednes­day morn­ing that it was stop­ping fur­ther work on an ex­per­i­men­tal drug for a rare ad­vanced eye can­cer that has spread to

While Nanobiotix would maintain operational control over the ongoing clinical studies, including NANORAY-312, Janssen would reserve the right to assume control of these studies. Image